Metastatic renal cell carcinoma treated with Peg-interferon alfa-2b. [electronic resource]
Producer: 20100202Description: 901-8 p. digitalISSN:- 1651-226X
- Aged
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Female
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Staging
- Polyethylene Glycols -- therapeutic use
- Prognosis
- Recombinant Proteins
- Risk Factors
- Survival Rate
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.